In acute promyelocytic leukemia (APL), IL-13-producing ILC2s participate in the establishment of a pro-tumor microenvironment by activating monocytic myeloid-derived suppressor cells (M-MDSCs) [5]. This evidence concerns the gene IL13 and acute promyelocytic leukemia.